No change in policy on itemised billing: MOH
Published on: Sunday, May 18, 2025
Published on: Sun, May 18, 2025
By: Bernama Text Size: Explaining further, the Ministry of Health is confident that good and continuous cooperation between all parties will continue to strengthen the quality of health services and safeguard the interests and welfare of patients together. - pix for illustration purposes only Kuala Lumpur: The Ministry of Health (MOH) clarified that there is no change in policy or announcement of a new policy regarding the implementation of itemised billing by private medical clinics. In a statement Saturday, MOH said the matter follows confusion arising regarding a statement made in a TikTok Live session regarding the requirement to provide itemised billing by private medical clinics.
Advertisement According to MOH, the session, which took place last Wednesday with the topic 'Myths and Facts' of Drug Price Display, was an information session for the public regarding implementing the drug price display initiative at private health facilities and community pharmacies. 'The patient's right to receive itemised bills is a matter provided for under the Private Healthcare Facilities and Services (Private Hospitals and Other Private Healthcare Facilities) Regulations 2006. 'The provision of itemised bills is only mandatory upon request without any additional charge, to facilitate understanding of the details of service charges, treatment and medicines received,' according to the statement. Explaining further, the Ministry of Health is confident that good and continuous cooperation between all parties will continue to strengthen the quality of health services and safeguard the interests and welfare of patients together.
Advertisement 'This is in line with the Government's commitment to implement Madani values to ensure that all parties, whether patients/customers or private medical providers, receive equal rights in all matters involving health aspects as a whole,' according to the statement. Last Thursday, the media reported that general practitioners (GPs) and private specialist clinics were required to issue itemised bills to patients as a measure to increase transparency through instructions on the display of drug prices, which came into effect on May 1. * Follow us on Instagram and join our Telegram and/or WhatsApp channel(s) for the latest news you don't want to miss. * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available.
Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
9 hours ago
- Malay Mail
First vape, next cake? The slippery slope of selective bans — Sim Tian Hong
JUNE 10 — The recent calls for a nationwide vape ban have been hogging the headlines. Just recently, Segamat MP R. Yuneswaran urged the Federal government to impose a blanket ban, citing rising healthcare costs and increasing youth vaping rates. Meanwhile, states such as Selangor, Kelantan, Johor, Negeri Sembilan and Terengganu have already moved ahead with bans of their own or are debating similar measures. These moves are driven by understandable public health concerns. No one is questioning the motivations behind such calls. After all, nothing is more important than public health. However, are we approaching this issue in a consistent and coherent way? If we are banning vape to protect public health, why are cigarettes — a product known to cause cancer, heart disease, and countless other illnesses — still legally sold and taxed? According to the Ministry of Health, tobacco use remains one of the most preventable causes of death in Malaysia. Yet, while vape is being banned or restricted in piecemeal fashion, cigarettes remain a fixture in convenience stores nationwide. The recent calls for a nationwide vape ban have been hogging the headlines. — Picture by Raymond Manuel This inconsistency becomes even more troubling when one considers the fragmented nature of the current policy response. Some states are imposing their own bans, others are not. The Federal government has yet to adopt a clear, unified stance. The result is a patchwork of differing rules across the country. This is bound to create confusion for the public, enforcement challenges for authorities, and opportunities for an illicit market to flourish. There is also the risk of setting a questionable policy precedent. If the principle is that we should ban products that can harm public health, where do we draw the line? Should we also move to ban junk food, sugary drinks, or alcohol, all of which contribute to non-communicable diseases and healthcare costs? I am not suggesting that we ignore the risks associated with vaping. But we should be wary of making selective, reactive policy decisions that are not grounded in a consistent framework. Rather than imposing outright bans in an uneven and fragmented way, there is a case for a more balanced and coherent approach. Stronger public education campaigns, tighter regulation of marketing and sales (especially to minors), and consistent enforcement across states may ultimately prove more effective than prohibition alone. Above all, public health policy should be seen as fair, rational, and consistent. A strategy that appears to single out certain products while ignoring others with well-documented harms, risks undermining public trust. It may also distract from the broader effort to build a healthier society. Public health must always come first. But in pursuing that goal, we should avoid the temptation to adopt inconsistent or populist measures that may generate headlines, but not necessarily better outcomes. * This is the personal opinion of the writer or publication and does not necessarily represent the views of Malay Mail.
Daily Express
12 hours ago
- Daily Express
Ispire Malaysia says Johor plant operating above board
Published on: Tuesday, June 10, 2025 Published on: Tue, Jun 10, 2025 By: FMT Reporters Text Size: Health minister Dzulkefly Ahmad had said that the Cabinet would decide on the fate of Ispire Malaysia Sdn Bhd's operations in Senai, Johor. (LinkedIn pic) PETALING JAYA: Ispire Malaysia Sdn Bhd today affirmed that its plant in Senai, Johor, which manufactures electronic cigarette devices, is fully compliant with local laws and regulations. In a statement, the firm said it operates under stringent procedures to ensure that all manufacturing activities at its Johor facility are exclusively for export purposes. Advertisement 'To date, Ispire Malaysia exclusively manufactures semi-finished hardware products destined solely for export. 'These products do not contain any nicotine or cannabis – liquid or gel – and thus are not subject to the health ministry's regulations under the Control of Smoking Products for Public Health Act 2024,' it said. It added that the products manufactured in its Johor facility are not marketed, sold, or distributed within Malaysia and not accessible to local consumers. All finished products are exported to regulated international markets such as the US and UK where they are approved for sale by local regulators, the company said. The firm also said that references cited in recent reports were largely drawn from Ispire's official US website and pertained to its business-to-business sales operations in jurisdictions where cannabis and related products are legal. 'These statements do not accurately reflect the operations of Ispire Malaysia, which strictly adheres to all Malaysian laws and regulatory requirements/frameworks,' it said. Health think tank CodeBlue previously reported that Ispire produces nicotine and cannabis-related vaping products, and that its devices are used by clients to fill cartridges with cannabis oils in global markets. The report cited an investor presentation in Las Vegas in April, published on YouTube on May 6, which stated that Ispire produces 'mainly cannabis-related products' in its Malaysian manufacturing facility, which has up to seven production lines. In a statement last week, the health ministry confirmed that the government had issued Ispire an interim nicotine manufacturing licence to produce e-cigarettes with nicotine in its plant in Johor, together with local council approval. However, CodeBlue noted that the ministry's June 2 statement did not mention the plant's production of cannabis vaporisers, which reportedly began in February 2024. Ispire Malaysia today said that any production of nicotine-based products, if initiated, would be strictly for export and subject to formal approval by all relevant government agencies at both federal and state levels. Yesterday, health minister Dzulkefly Ahmad said that the Cabinet would decide on the fate of Ispire's operations in Malaysia. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
![[UPDATED] Zahid-led panel to tackle stagnant GP fees](/_next/image?url=https%3A%2F%2Fassets.nst.com.my%2Fimages%2Farticles%2Fasnisninid_1749442281.jpg&w=3840&q=100)
![[UPDATED] Zahid-led panel to tackle stagnant GP fees](/_next/image?url=https%3A%2F%2Fassets.nst.com.my%2Fassets%2FNST-Logo%402x.png%3Fid%3Db37a17055cb1ffea01f5&w=48&q=75){kind=small}
New Straits Times
a day ago
- New Straits Times
[UPDATED] Zahid-led panel to tackle stagnant GP fees
KUALA LUMPUR: A high-level committee chaired by Deputy Prime Minister Datuk Seri Dr Ahmad Zahid Hamidi will review the Health Ministry's findings on the long-standing issue of stagnant consultation fees for private general practitioners (GPs). Health Minister Datuk Seri Dr Dzulkefly Ahmad said the committee would refine the ministry's recommendations before they are presented to the government for a final decision. "No date has been set yet," he told a press conference today, but gave his assurance that the matter would be tabled "in the near future." He said the decision to escalate the issue followed discussions between the Health Ministry and the National Action Council on Cost of Living (Naccol). On May 3, Dzulkefly announced that the review of private GP consultation fees was expected to be finalised within a month. He also said cabinet approval was the final step required before the amendments could be implemented. GP consultation fees are regulated under the Seventh Schedule of the Private Healthcare Facilities and Services (Private Medical Clinics or Private Dental Clinics) Regulations 2006, under the Healthcare Facilities and Services Act 1998. On April 8, Dzulkefly said the ministry was awaiting a decision from the Finance Ministry on the proposed revision. He had earlier confirmed on March 4 that the fees had not been revised for nearly two decades.
